Visit Sciex Diagnostics for more information about solutions in mass spectrometry paired with liquid chromatography.
Migrating from immunoassay to mass spectrometry is a challenging endeavor for laboratories aiming to update their equipment and expand their diagnostic portfolios. Caroline le Goff, a European specialist in laboratory medicine based in Liège, Belgium, will share her experience making this transition and detail the evaluation of a kit "ready to use" for steroid panel and validation of an in-house method . She will also discuss method comparison, results validation, and going live with the assay.
This pre-recorded webinar will be available to view on Wednesday, September 19, 2018 @ 1:00PM ET. At that time, you will receive an email with the direct link for viewing. You must register to receive access to view the recording.
WHAT YOU WILL LEARN
Understand the difference between an in-house method and a ready to use method concerning the analytical validation and method development.
Understand what is needed when validating a new technology to an existing workflow.
- Evaluate the results obtained in comparison to literature.
Caroline Le Goff, EuSpLM
Clinical Biologist, Department of Clinical Chemistry
University of Liège, CHU Sart-Tilman